Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

SRZN Surrozen Inc

14,23

-2,79 (-16,39%)

06 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Surrozen Charts.

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Surrozen Charts.

News Surrozen Inc

Surrozen to Present at Upcoming Healthcare Investor Conferences
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Surrozen Provides Third Quarter 2024 Financial Results and Business Update
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis
Montag 4 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
Dienstag 24 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 12 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Surrozen Provides Second Quarter 2024 Financial Results and Business Update
Montag 12 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
Mittwoch 12 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
Montag 10 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Dienstag 4 Juni 2024 (7 Monate vor) • GlobeNewswire Inc.

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Donnerstag 9 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Surrozen Provides First Quarter 2024 Financial Results and Business Update
Mittwoch 8 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Weitere Surrozen Inc News-Artikel

Financial Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen